Cadrenal Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2022 to 2023.
  • Cadrenal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $300K, a 96% increase year-over-year.
  • Cadrenal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $759K.
  • Cadrenal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $710K, a 23.5% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $710K -$218K -23.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $928K Jan 25, 2022 Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.